Multimorbidity and the Number of Conditions Increase With the Duration of Type 1 Diabetes and Associate With Increased Mortality
Journal of Diabetes · 2026-06 · 18 (6)
DOI: 10.1111/1753-0407.70249 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Diabetes, online erschienen am 18.06.2026. Verfasst von Anni Ylinen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Folkhälsan Research Center, Biomedicum Helsinki, Helsinki, Finland. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Multimorbidity. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Folkhälsanin Tutkimussäätiö, Wilhelm och Else Stockmanns Stiftelse, Medicinska Understödsföreningen Liv och Hälsa.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Multimorbidity in type 1 diabetes has previously not been studied in detail. Therefore, we aimed to assess the prevalence of multimorbidity and its association with mortality in type 1 diabetes.
Methods
This observational follow‐up study includes 4069 individuals with type 1 diabetes from the Finnish Diabetic Nephropathy study. The prevalence of multimorbidity (coexistence of two or more chronic conditions) was based on 32 conditions at baseline. Conditions were grouped into three subcategories: vascular comorbidities, autoimmune disorders, and other conditions. Hazard ratios (HR) for all‐cause mortality were calculated.
Results
The prevalence of multimorbidity was 60.4% and increased with age and especially diabetes duration. Multimorbidity was associated with increased risk of mortality, HR 6.0 (95% CI 4.6–7.8), p < 0.001. The HR for mortality increased by each additional condition and was 37.9 (95% CI 25.7–56.0) in those with ≥eight conditions. Vascular comorbidities and other conditions were associated with increased mortality, HRs 5.9 (4.4–7.9) and 3.8 (2.4–5.9), p < 0.001, separately, and in combination, HR 11.2 (8.3–15.2), p < 0.001. Autoimmune disorders did not influence mortality.
Conclusions
Multimorbidity in type 1 diabetes is common and is associated with increased mortality. Comprehensive evaluation of all additional conditions is needed to tailor treatment individually.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Folkhälsan Research Center, Biomedicum Helsinki, Helsinki, Finland.
- Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
- Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
- Department of General Practice and Primary Health Care, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
- Department of Diabetes, Central Clinical School, Monash University, Melbourne, Victoria, Australia.
- Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
ORCID-Profile: Per-Henrik Groop, Lena M Thorn
Förderung
- Folkhälsanin Tutkimussäätiö
- Wilhelm och Else Stockmanns Stiftelse
- Medicinska Understödsföreningen Liv och Hälsa
- Sigrid Juséliuksen Säätiö
- Finska Läkaresällskapet
- Helsinki University Hospital
- Stiftelsen Dorothea Olivia, Karl Walter och Jarl Walter Perkléns Minne
- Biomedicum Helsinki-säätiö
Zitieren
APA
Ylinen, A., Mutter, S., Hägg-Holmberg, S., Satuli-Autere, S., Harjutsalo, V., Groop, P. H., Thorn, L. M., & FinnDiane Study Group (2026). Multimorbidity and the Number of Conditions Increase With the Duration of Type 1 Diabetes and Associate With Increased Mortality. Journal of Diabetes, 18(6). https://doi.org/10.1111/1753-0407.70249
Vancouver
Ylinen A, Mutter S, Hägg-Holmberg S, Satuli-Autere S, Harjutsalo V, Groop PH, et al. Multimorbidity and the Number of Conditions Increase With the Duration of Type 1 Diabetes and Associate With Increased Mortality. Journal of Diabetes. 2026;18(6). doi:10.1111/1753-0407.70249
BibTeX
@article{Ylinen2026,
author = {Ylinen, Anni and Mutter, Stefan and Hägg-Holmberg, Stefanie and Satuli-Autere, Susanna and Harjutsalo, Valma and Groop, Per-Henrik and Thorn, Lena M and FinnDiane Study Group, FinnDiane Study Group},
title = {Multimorbidity and the Number of Conditions Increase With the Duration of Type 1 Diabetes and Associate With Increased Mortality},
journal = {Journal of Diabetes},
year = {2026},
volume = {18},
number = {6},
doi = {10.1111/1753-0407.70249}
}
EUVIMED